Automated description from the Alliance of Genome Resources (Release 3.2)
Predicted to have extracellular matrix structural constituent and heparin binding activity. Involved in endochondral ossification and morphogenesis of a branching structure. Localizes to cell-cell junction. Is expressed in several structures, including genitourinary system; heart and pericardium; jaw; musculoskeletal system; and respiratory system. Used to study congenital myasthenic syndrome 19. Human ortholog(s) of this gene implicated in congenital myasthenic syndrome 19. Orthologous to human COL13A1 (collagen type XIII alpha 1 chain).